Guardant Health, Inc. NMS · GH

$151.91 +3.84 (+2.59%)

Neutral · +0.03σ

+ Compare Open in Sniper

Valuation

Market cap $20.1B

P/E (ttm) —

Forward P/E -350.7

Beta (5y) 1.59

Shares out 132.6M

Div yield —

Profitability & returns

ROE —

Net margin -40.1%

FCF margin -7.9%

Debt / equity —

Trading information

Last price $151.91

Day range $144.89 – $152.73

52-wk range $74.55 – $174.08

Avg volume 2.7M

RSI (2) 46.5

Trend zone Neutral

52-week range · today's price

$74.55$174.08

Company

Sector Healthcare

Industry Diagnostics & Research

Exchange NMS

Next earnings 2026-07-30

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect can…